Public Company News

SK hynix Develops Industry's First 1c DDR5

* 1c node, 6th generation of 10nm process, developed in most efficient way by applying platform of industry-leading1b technology * Cost competitiveness improved with adoption of new material, optimization of EUV process, while power efficiency enhanced to help reduce electricity cost of data ...

2024-08-29 08:00 2449

Tantech Holdings Ltd Receives NASDAQ Minimum Bid Price Requirement Extension

LISHUI, China, Aug. 28, 2024 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), announced today that onAugust 27, 2024, it received notification from The Nasdaq Stock Market LLC ("NASDAQ") confirming the Company has been granted an additional 180 calendar day period...

2024-08-29 05:00 5208

NOAH HOLDINGS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2024

SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for Mandarin-speaking...

2024-08-29 04:45 5416

Noah Holdings Announces US$50 Million Share Repurchase Program

SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for Mandarin-speaking...

2024-08-29 04:40 3404

Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization

* Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS, and is also the only study to achieve the primary endpoint while showing a positive trend in OS benefit; HARMONi-A study presented in an oral p...

2024-08-29 04:20 3244

Jenscare, with innovative TTVR, releases 2024H1 interim results

BEIJING, Aug. 28, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, released interim results for 2024H1 endedJune 30, 2024...

2024-08-28 21:00 3219

MDJM LTD Announces Appointment of William Wang as Director for its Cultural Business Development in England

LETHAM, Scotland, Aug. 28, 2024 /PRNewswire/ -- MDJM LTD (Nasdaq: MDJH) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced the appointment ofWilliam Bo Wang as a board member and Director of its wholly owned subsidiary, MANSIONS CATERING AND H...

2024-08-28 20:30 2900

Hyundai Mobis Accelerates Development of Sustainable Recyclable Materials and Innovative Substitutes for Rare Raw Materials

* Focus on Three Strategic Areas for Next-Generation Core Materials: Sustainable materials, innovative mobility materials, and digital materials * Enhancing Competitiveness of Electrification and Electronic Components While Meeting Global Environmental Regulations * Strengthening Independent...

2024-08-28 20:00 2554

HEVI Unveils North America's Largest All-Electric Wheel Loader: Game-Changing H65L Delivers Zero Emissions, Lower Costs, and Uncompromised Performance

EAST WINDSOR, N.J., Aug. 28, 2024 /PRNewswire/ -- HEVI Corp. ("HEVI" or the "Company"), a manufacturer of all-electric heavy equipment, today unveiled its game changing all electric vehicle, model H65L. With a nearly 50,000 pound operating weight, HEVI's new flagship H65L all electric wheel loade...

2024-08-28 19:00 3016

Mega Matrix Announces FlexTV's Surge to Top 4 on the App Store Entertainment Chart (Free Apps, Saudi Arabia) as of August 27, 2024

PALO ALTO, Calif., Aug. 28, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that FlexTV, its short drama streaming platform, has ranked No.4 in the App Store Entertainment Chart (Free Apps,Saudi Arabia) as of August 27, 2024. 

2024-08-28 18:30 2173

Tigermed Reports 2024 Interim Results

HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its int...

2024-08-28 18:26 3677

Fosun Pharma Announces 2024 Interim Results

Breakthroughs for Innovative Products Going Overseas with Global Operation Capabilities Continuing to Strengthen SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- On August 27, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH; 02196.HK), announced its o...

2024-08-28 18:10 5348

Quhuo Reports Unaudited Financial Results for the First Half of 2024

BEIJING, Aug. 28, 2024 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on local life services inChina, today reported its unaudited financial results for the six months endedJune 30, 2024. Financial and Operational Highl...

2024-08-28 18:00 2577

Quhuo Announces Unaudited Financial Results for the First Half of 2024: Precise Strategy Spurs Strong Growth in Mobility Service and Homestay

* Revenues from mobility service solutions were RMB100.5 million (US$13.8 million), representing an increase of 71.7% year-over-year. * Quhuo International shipped 815 vehicles under its vehicle export solutions. * The Company has expanded services to 132 cities nationwide, representing a 21....

2024-08-28 18:00 2823

Harbour BioMed Announces 2024 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology an...

2024-08-28 17:44 2913

Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization

* "Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" * "While maintaining the current process for emergency use authorization for mild-to-moderate COVID-19 patients, Hyundai Bioscience will expedite Phase 3 clinical tr...

2024-08-28 17:29 2393

Achieva Medical Entered into an Exclusive Distribution Agreement with NowYon Medical

SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its wholly-owned subsidiary, Achieva Medical Limited ("Achieva Medical"), entered ...

2024-08-28 16:40 3384

Haitian Mexico Open Day: A New Chapter of Regional Strategy

GUADALAJARA, Mexico, Aug. 27, 2024 /PRNewswire/ -- In mid-August, Haitian Mexico held a grand Open Day inGuadalajara, Mexico. This event not only allowed local customers to learn about Haitian International's latest technological innovations but also served as a comprehensive display of the compa...

2024-08-28 15:47 2152

"Bleach: Brave Souls" 95 Million Downloads Celebration Campaign Begins Alongside the Thousand-Year Blood War Zenith Summons: Preeminence

TOKYO, Aug. 28, 2024 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its hit 3D action game Bleach: Brave Souls has reached a total of 95 million downloads* worldwide. See theoriginal press release (https://www.klab.com/en/press/

2024-08-28 15:40 2215

Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist

SEOUL, South Korea, Aug. 27, 2024 /PRNewswire/ -- Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has cleared the IND application of Phase 1 Multiple Ascending Dose (MAD) study for ID110521156, an oral...

2024-08-28 10:43 2273
1 ... 235236237238239240241 ... 769

Week's Top Stories